Chiung-chih K. Chang

No 70, Lienhai Road
Kaohsiung, KHQ 80424, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 133 publications

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

Journal: JAMA

Published: July 13, 2026

Selective white matter tract vulnerability associated with tau burden in progressive supranuclear palsy and Alzheimer's disease.

Selective white matter tract vulnerability associated with tau burden in progressive supranuclear palsy and Alzheimer's disease.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 26, 2026

Plasma pTau217 and Neurofilament Light Chain as Differentiative Markers for Progressive Supranuclear Palsy From Parkinson Disease.

Plasma pTau217 and Neurofilament Light Chain as Differentiative Markers for Progressive Supranuclear Palsy From Parkinson Disease.

Journal: Neurology

Published: December 12, 2025

Assessing glymphatic function in schizophrenia and mood disorders: Insights from a diffusion tensor image along the perivascular space (DTI-ALPS) and neuroanatomical correlations.

Assessing glymphatic function in schizophrenia and mood disorders: Insights from a diffusion tensor image along the perivascular space (DTI-ALPS) and neuroanatomical correlations.

Journal: Psychiatry and clinical neurosciences

Published: July 20, 2025

Disentangling tau, glymphatic dysfunction and astrocytic activation in amyloid-positive Alzheimer's disease.

Disentangling tau, glymphatic dysfunction and astrocytic activation in amyloid-positive Alzheimer's disease.

Journal: Mechanisms of ageing and development

Published: June 23, 2025

Visual interpretation of [18F]Florzolotau Tau-PET imaging for differentiating alzheimer's disease and progressive supranuclear palsy.

Visual interpretation of [18F]Florzolotau Tau-PET imaging for differentiating alzheimer's disease and progressive supranuclear palsy.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 12, 2025

Optimizing timing and cost-effective use of plasma biomarkers in Alzheimer's disease.

Optimizing timing and cost-effective use of plasma biomarkers in Alzheimer's disease.

Journal: Alzheimer's research & therapy

Published: April 22, 2025

Functional connectivity density as a biomarker for Alzheimer's disease: Distinct neural mechanisms in young- and late-onset subtypes.

Functional connectivity density as a biomarker for Alzheimer's disease: Distinct neural mechanisms in young- and late-onset subtypes.

Journal: Psychiatry and clinical neurosciences

Published: April 16, 2025

Role of glymphatic system function in cognitive dysfunction among patients with bipolar disorder.

Role of glymphatic system function in cognitive dysfunction among patients with bipolar disorder.

Journal: The international journal of neuropsychopharmacology

Published: April 03, 2025

Development of Machine-Learning-Based Models for Detection of Cognitive Impairment in Patients Receiving Maintenance Hemodialysis.

Development of Machine-Learning-Based Models for Detection of Cognitive Impairment in Patients Receiving Maintenance Hemodialysis.

Journal: European journal of neurology

Published: November 05, 2024

Clinical impact of pharmacogenetic risk variants in a large chinese cohort.

Clinical impact of pharmacogenetic risk variants in a large chinese cohort.

Journal: Nature communications

Published: October 25, 2024

Development and validation of global tau severity score in Alzheimer's disease using Florzolotau (18F) PET.

Development and validation of global tau severity score in Alzheimer's disease using Florzolotau (18F) PET.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: October 22, 2024

Showing 1-12 of 133

Last Updated: 09/26/2026